公开(公告)号：US20200222495A1

公开(公告)日：2020-07-16

申请号：US16302786

申请日：2017-05-18

Applicant: UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO

Inventor： Edda Lydia Sciutto Conde ,  Gladis del Carmen Fragoso Gonzalez ,  Diana Torres Garcia ,  Jacquelynne Brenda Cervantes Torres ,  Rene Alvaro Segura Velazquez ,  Armando Perez Torres ,  Karen Manucharyan

IPC: A61K38/10 ,  A61P35/00

Abstract: The present invention refers to the use of the peptide defined by the amino acid sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A, named GK-1, to be used as an antitumor and antimetastatic agent or for the treatment of cancer, specifically of basal cell carcinoma, squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma, and preferably for the treatment of breast cancer.

公开(公告)号：US11020449B2

公开(公告)日：2021-06-01

申请号：US16302786

申请日：2017-05-18

Applicant: UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO

Inventor： Edda Lydia Sciutto Conde ,  Gladis del Carmen Fragoso Gonzalez ,  Diana Torres Garcia ,  Jacquelynne Brenda Cervantes Torres ,  Rene Alvaro Segura Velazquez ,  Armando Perez Torres ,  Karen Manucharyan

IPC: A61K38/10 ,  A61P35/00

Abstract: The present invention refers to the use of the peptide defined by the amino acid sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A, named GK-1, to be used as an antitumor and antimetastatic agent or for the treatment of cancer, specifically of basal cell carcinoma, squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma, and preferably for the treatment of breast cancer.